Apollo Scientific @ InformEx USA 2010, stand 535

Published: 10-Feb-2010

Apollo Scientific is a worldwide supplier of a broad and impressively diverse range of intermediates from lab-scale to commercial quantities. At present we have a total of more than 44,000 products across all our ranges. These include almost 13,000 fluorine containing compounds, 27,000 non-fluorinated intermediates, 1,000 high purity inorganic salts and more than 2,500 reagents for plant and molecular biology.
Central Glass Inc (Japan) is now the majority shareholder in Apollo and this gives us the facility to support your project from conception to commercial realisation.
  • Companies:
  • Informa
See more

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Read more
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Of data, devices and drug delivery

Ahead of Pharmapack Europe 2025 (22–23January, Paris, France), Dr Kevin Robinson (KSR) spoke with three pharma leaders about the big trends that will drive and influence the pharmaceutical sector in 2025
Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025
Pharmaceutical

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony
Ingredients

CPHI Milan Annual Report 2024

Ahead of next month’s CPHI Milan — where the industry is expected to turnout in record numbers with a staggering 62,000 pharma executives expected from more than 100 countries — Manufacturing Chemist got a sneak preview of the CPHI Annual Reports Excipients Analysis featuring Ian Moore’s (former Chair of the IPEC Europe GMP Committee) personal predictions for the year ahead
Manufacturing

Rapid increase in purchasing teams expected at CPHI North America

Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
Packaging

Contract packaging predicted to see high growth in 2024 ahead of Pharmapack Europe

Ninety four per cent of the industry are either "highly positive" or "moderately positive" about growth prospects for 2024
Subscribe now